Primary Spinal Astrocytomas: A Literature Review

John Ogunlade, James G Wiginton 4th, Christopher Elia, Tiffany Odell, Sanjay C Rao, John Ogunlade, James G Wiginton 4th, Christopher Elia, Tiffany Odell, Sanjay C Rao

Abstract

Primary spinal astrocytoma is a subtype of glioma, the most common spinal cord tumor found in the intradural intramedullary compartment. Spinal astrocytomas account for 6-8% of all spinal cord tumors and are primarily low grade (World Health Organization grade I (WHO I) or WHO II). They are seen in both the adult and pediatric population with the most common presenting symptoms being back pain, sensory dysfunction, or motor dysfunction. Magnetic Resonance Imaging (MRI) with and without gadolinium is the imaging of choice, which usually reveals a hypointense T1 weighted and hyperintense T2 weighted lesion with a heterogeneous pattern of contrast enhancement. Further imaging which may aid in surgical planning includes computerized tomography, diffusion tensor imaging, and tractography. Median survival in spinal cord astrocytomas ranges widely. The factors most significantly associated with poor prognosis and shorter median survival are older age at initial diagnosis, higher grade lesion based on histology, and extent of resection. The mainstay of treatment for primary spinal cord astrocytomas is surgical resection, with the goal of preservation of neurologic function, guided by intraoperative neuromonitoring. Adjunctive radiation has been shown beneficial and may increase overall survival. The role of adjunctive chemotherapy is employed, however, its benefit has not been clearly defined. Primary spinal cord astrocytomas are rare and challenging to treat. The gold standard treatment is surgical resection. Second-line treatments include radiation and chemotherapy, although, the optimal regimen for adjunctive therapy has not yet been clearly defined.

Keywords: astrocytoma; glioblastoma; glioma; intradural; intramedullary; spinal astrocytoma; spinal cord neoplasms; spinal tumor.

Conflict of interest statement

The authors have declared that no competing interests exist.

Copyright © 2019, Ogunlade et al.

Figures

Figure 1. Pilocytic astrocytoma of the thoracic…
Figure 1. Pilocytic astrocytoma of the thoracic spine.
A) T1-weighted sagittal pre-contrast image, B) T1-weighted sagittal post-contrast image, and C) T2-weighted axial slice showing displacement of thoracic cord by area of hyperintensity consistent with spinal astrocytoma. Photo Reference: Courtesy of Assoc. Prof. Frank Gaillard, Radiopaedia.org, rID: 19536
Figure 2. High-grade astrocytoma of the thoracic…
Figure 2. High-grade astrocytoma of the thoracic spine.
A) T1-weighted sagittal pre-contrast image, B) T1-weighted sagittal post-contrast image, and C) T2-weighted axial slice showing displacement of the thoracic cord by area of hyperintensity consistent with spinal astrocytoma. Photo Reference: Courtesy of Assoc. Prof. Frank Gaillard, Radiopaedia.org, rID: 19536

References

    1. Intramedullary spinal cord tumors: molecular insights and surgical innovation. Parsa AT, Chi JH, Acosta FL, Ames CP, McCormick PC. . Clin Neurosurg. 2005;52:76–84.
    1. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. Lonser RR, Weil RJ, Wanebo JE, Devroom HL, Oldfield EH. J Neurosurg. 2003;98:106–116.
    1. Primary spinal cord glioma: a surveillance, epidemiology, and end results database study. Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA. J Neurooncol. 2010;98:83–92.
    1. Intramedullary spinal cord tumors: a review of current and future treatment strategies. Tobin MK, Geraghty JR, Engelhard HH, Linninger AA, Mehta AI. Neurosurg Focus. 2015;39:14.
    1. Prognosis and treatment of spinal cord astrocytoma. Minehan KJ, Brown PD, Scheithauer BW, Krauss WE, Wright MP. Int J Radiat Oncol Biol Phys. 2009;73:727–733.
    1. Long-term follow-up of intramedullary spinal cord tumors: a series of 202 cases. Raco A, Esposito V, Lenzi J, Piccirilli M, Delfini R, Cantore G. Neurosurgery. 2005;56:972–981.
    1. Adult primary intradural spinal cord tumors: a review. Chamberlain MC, Tredway TL. Curr Neurol Neurosci Rep. 2011;11:320–328.
    1. Survival analysis of 459 adult patients with primary spinal cancer in England and Wales: a population-based study. Tseng JH, Tseng MY. Surg Neurol. 2007;67:53–58.
    1. Intramedullary spinal cord tumors: part I—epidemiology, pathophysiology, and diagnosis. Samartzis D, Gillis CC, Shih P, O’Toole JE, Fessler RG. Global Spine J. 2015;5:425–435.
    1. High-grade intramedullary astrocytomas: 30 years’ experience at the Neurosurgery Department of the University of Rome “Sapienza”. Raco A, Piccirilli M, Landi A, Lenzi J, Delfini R, Cantore G. J Neurosurg Spine. 2010;12:144–153.
    1. Intradural spinal tumors: current classification and MRI features. Abul-Kasim K, Thurnher MM, McKeever P, Sundgren PC. Neuroradiology. 2008;50:301–314.
    1. Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Koeller KK, Rosenblum RS, Morrison AL. Radiographics. 2000;20:1721–1749.
    1. Spinal cord ependymoma: a review of the literature and case series of ten patients. Celano E, Salehani A, Malcolm JG, Reinertsen E, Hadjipanayis CG. J Neurooncol. 2016;128:377–386.
    1. Surgical treatment of spinal cord astrocytomas of childhood. Epstein F, Epstein N. J Neurosurg. 1982;57:685–689.
    1. Intramedullary spinal cord tumors in children under the age of 3 years. Constantini S, Houten J, Miller DC, et al. J Neurosurg. 1996;85:1036–1043.
    1. Nonenhancing intramedullary astrocytomas and other MR imaging features: a retrospective study and systematic review. Seo HS, Kim JH, Lee DH, Lee YH, Suh SI, Kim SY, Na DG. AJNR Am J Neuroradiol. 2010;31:498–503.
    1. MR diffusion tensor imaging and fiber tracking in 5 spinal cord astrocytomas. Ducreux D, Lepeintre JF, Fillard P, Loureiro C, Tadié M, Lasjaunias P. . AJNR Am J Neuroradiol. 2006;27:214–216.
    1. Axial MR diffusion tensor imaging and tractography in clinical diagnosed and pathology confirmed cervical spinal cord astrocytoma. Zhao M, Shi B, Chen T, et al. J Neurol Sci. 2017;375:43–51.
    1. Multifocal intradural extramedullary pilocytic astrocytomas of the spinal cord: a case report and review of the literature. Basheer A, Rammo R, Kalkanis S, Felicella MM, Chedid M. Neurosurgery. 2017;80:178–184.
    1. Spinal cord astrocytoma: pathological and treatment considerations. Minehan KJ, Shaw EG, Scheithauer BW, Davis DL, Onofrio BM. J Neurosurg. 1995;83:590–595.
    1. Prognostic factors and survival in primary malignant astrocytomas of the spinal cord: a population-based analysis from 1973 to 2007. Adams H, Avendaño J, Raza SM, Gokaslan ZL, Jallo GI, Quiñones-Hinojosa A. Spine. 2012;37:727–735.
    1. Malignant astrocytomas of the spinal cord. Cohen AR, Wisoff JH, Allen JC, Epstein F. J Neurosurg. 1989;70:50–54.
    1. Risk factors and long-term survival in adult patients with primary malignant spinal cord astrocytomas. Wong AP, Dahdaleh NS, Fessler RG, Melkonian SC, Lin Y, Smith ZA, Lam SK. J Neurooncol. 2013;115:493–503.
    1. Primary spinal glioblastoma multiforme: a case report and review of the literature. Shen CX, Wu JF, Zhao W, Cai ZW, Cai RZ, Chen CM. Medicine. 2017;96:6634.
    1. Radiotherapy of spinal cord gliomas: a retrospective mono-institutional analysis. Corradini S, Hadi I, Hankel V, Ertl L, Ganswindt U, Belka C, Niyazi M. Strahlenther Onkol. 2016;192:139–145.
    1. Adult intramedullary astrocytomas of the spinal cord. Epstein FJ, Farmer JP, Freed D. J Neurosurg. 1992;77:355–359.
    1. Spinal cord glioblastoma: 25 years of experience from a single institution. Yanamadala V, Koffie RM, Shankar GM, et al. J Clin Neurosci. 2016;27:138–141.
    1. Primary spinal glioblastoma multiforme with secondary manifestation as a cerebral “Angioglioma.” Literature review and case report. Linsenmann T, Westermaier T, Vince G, Monoranu CM, Löhr M, Ernestus RI, Stetter C. J Neurol Surg Rep. 2015;76:128–134.
    1. Targeted treatment of experimental spinal cord glioma with dual gene-engineered human neural stem cells. Ropper AE, Zeng X, Haragopal H, et al. Neurosurgery. 2016;79:481–491.
    1. Extent of surgical resection of malignant astrocytomas of the spinal cord. McGirt MJ, Goldstein IM, Chaichana KL, Tobias ME, Kothbauer KF, Jallo GI. Neurosurgery. 2008;63:55–61.
    1. Spinal cord astrocytomas: presentation, management and outcome. Houten JK, Cooper PR. J Neurooncol. 2000;47:219–224.
    1. Spinal cord astrocytomas: a modern 20-year experience at a single institution. Babu R, Karikari IO, Owens TR, Bagley CA. Spine. 2014;39:533–540.
    1. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases. Garcés-Ambrossi GL, McGirt MJ, Mehta VA, et al. J Neurosurg Spine. 2009;11:591–599.
    1. Surgery for intramedullary spinal cord tumors: the role of intraoperative (neurophysiological) monitoring. Sala F, Bricolo A, Faccioli F, Lanteri P, Gerosa M. Eur Spine J. 2007;16:130–139.
    1. Infiltrating spinal cord astrocytomas: epidemiology, diagnosis, treatments and future directions. Abd-El-Barr MM, Huang KT, Chi JH. J Clin Neurosci. 2016;29:15–20.
    1. Spinal cord gliomas: a multi-institutional retrospective analysis. Abdel-Wahab M, Etuk B, Palermo J, et al. Int J Radiat Oncol Biol Phys. 2006;64:1060–1071.
    1. Early radiation-induced endothelial cell loss and blood-spinal cord barrier breakdown in the rat spinal cord. Li YQ, Chen P, Jain V, Reilly RM, Wong CS. Radiat Res. 2004;161:143–152.
    1. Radiation-induced spinal glioblastoma multiforme: a rare complication in the management of head and neck cancer. Ju AW, Robins HI, Salamat MS, Grayev AM, Howard SP. Int J Otolaryngol Head Neck Surg. 2016;5:233–241.
    1. The genetic basis of intradural spinal tumors and its impact on clinical treatment. Karsy M, Guan J, Sivakumar W, Neil JA, Schmidt MH, Mahan MA. Neurosurg Focus. 2015;39:3.
    1. Spinal cord astrocytoma: response to PCV chemotherapy. Henson JW, Thornton AF, Louis DN. Neurology. 2000;54:518.
    1. Temozolomide for recurrent low-grade spinal cord gliomas in adults. Chamberlain MC. Cancer. 2008;113:1019–1024.

Source: PubMed

3
Iratkozz fel